The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma

Journal of Clinical Investigation

Volumn 123, Issue 2, 2013, Pages 855-865

  Parker, Brittany C ^a,b   Annala, Matti J ^a,c   Cogdell, David E ^a   Granberg, Kirsi J ^a,c   Sun, Yan ^a,d   Ji, Ping ^a   Li, Xia ^a   Gumin, Joy ^e   Zheng, Hong ^d   Hu, Limei ^a   Yli Harja, Olli ^c   Haapasalo, Hannu ^f   Visakorpi, Tapio ^g   Liu, Xiuping ^e   Liu, Chang Gong ^e   Sawaya, Raymond ^e   Fuller, Gregory N ^a   Chen, Kexin ^d   Lang, Frederick F ^b,e   Nykter, Matti ^c   Zhang, Wei ^a,b   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TIANJIN MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS   (United States)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

^g Institute of Biomedical Technology   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 3; MICRORNA; MICRORNA 99A; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN; SCATTER FACTOR RECEPTOR; TRANSFORMING ACIDIC COILED COIL CONTAINING PROTEIN 3; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; FUSION GENE; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR XENOGRAFT;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 4; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FUSION; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; RNA, NEOPLASM; TANDEM REPEAT SEQUENCES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84873347374     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI67144     Document Type: Article

References (41)

1. Croce CM. Chromosome translocations and human cancer. Cancer Res. 1986;46:6019-6023.
2. Delattre O, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;359(6391):162-165.
3. Clark J, et al. Identification of novel genes, SYT and SSX, involved in the t (X;18) (p11.2; q11.2) translocation found in human synovial sarcoma. Nat Genet. 1994;7(4):502-508.
4. Tomlins SA, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310(5748):644-648.
5. Palanisamy N, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med. 2010;16(7):793-798.
6. Soda M, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561-566.
7. Rikova K, et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007;131(6):1190-1203.
8. Tognon C, et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002;2(5):367-376.
9. Salzman J, et al. ESRRA-C11orf20 is a recurrent gene fusion in serous ovarian carcinoma. PLoS Biol. 2011;9(9):e1001156.
10. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature. 1985;315(6020):550-554.
11. Chung EY, et al. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther. 2008;7(11):1758-1764.
12. Zhao H, Kalota A, Jin S, Gewirtz AM. The c-myb proto-oncogene and microRNA-15a comprise an active autoregulatory feedback loop in human hematopoietic cells. Blood. 2009;113(3):505-516.
13. Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A. 2009;106(44):18740-18744.
14. Druker BJ, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355(23):2408-2417.
15. Shaw AT, et al. Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol. 2011;12(11):1004-1012.
16. Stupp R, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study:5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459-466.
17. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
18. Liu KW, Hu B, Cheng SY. Platelet-derived growth factor receptor alpha in glioma: a bad seed. Chin J Cancer. 2011;30(9):590-602.
19. Jones D, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008;68(21):8673-8677.
20. Bralten LB, et al. Integrated genomic profiling identifies candidate genes implicated in gliomagenesis and a novel LEO1-SLC12A1 fusion gene. Genes Chromosomes Cancer. 2010;49(6):509-517.
21. Singh D, et al. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science. 2012;337(6099):1231-1235.
22. Cappellen D, et al. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nat Genet. 1999;23(1):18-20.
23. Gergely F, Kidd D, Jeffers K, Wakefield JG, Raff JW. D-TACC: a novel centrosomal protein required for normal spindle function in the early Drosophila embryo. EMBO J. 2000;19(2):241-252.
24. Still IH, Vince P, Cowell JK. The third member of the transforming acidic coiled coil-containing gene family, TACC3, maps in 4p16, close to translocation breakpoints in multiple myeloma, and is upregulated in various cancer cell lines. Genomics. 1999;58(2):165-170.
25. Chen F, Hristova K. The physical basis of FGFR3 response to fgf1 and fgf2. Biochemistry. 2011;50(40):8576-8582.
26. Akiva P, et al. Transcription-mediated gene fusion in the human genome. Genome Res. 2006;16(1):30-36.
27. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15-20.
28. Oneyama C, et al. MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. Oncogene. 2011;30(32):3489-3501.
29. Song T, et al. Differential miRNA expression profiles in bladder urothelial carcinomas. Asian Pac J Cancer Prev. 2010;11(4):905-911.
30. Kang J, et al. microRNA-99b acts as a tumor suppressor in non-small cell lung cancer by directly targeting fibroblast growth factor receptor 3. Exp Ther Med. 2012;3(1):149-153.
31. Chang H, Stewart AK, Qi XY, Li ZH, Yi QL, Trudel S. Immunohistochemistry accurately predicts FGFR3 aberrant expression and t (4;14) in multiple myeloma. Blood. 2005;106(1):353-355.
32. Gómez-Román JJ, et al. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth. Clin Cancer Res. 2005;11(2 pt 1):459-465.
33. Ma XJ, et al. Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci U S A. 2003;100(10):5974-5979.
34. Jung CK, Jung JH, Park GS, Lee A, Kang CS, Lee KY. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer. Pathol Int. 2006;56(9):503-509.
35. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009;10(3):R25.
36. Moore L, et al. Transcriptome and small RNA deep sequencing reveals deregulation of miRNA biogenesis in human glioma [published online ahead of print September 24, 2012]. J Pathol. doi:10.1002/path.4109.
37. Olshen AB, Venkatraman ES, Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004;5(4):557-572.
38. Wang H, et al. Insulin-like Growth Factor Binding Protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res. 2003;63(15):4315-4321.
39. Irizarry RA, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249-264.
40. Lal S, Lacroix M, Tofilon P, Fuller GN, Sawaya R, Lang FF. An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg. 2000;92(2):326-333.
41. Nakamizo A, et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005;65(8):3307-3318.